Related Experiment Videos
Connective eccentricity index: a novel topological descriptor for predicting biological activity
1Department of Pharmaceutical Sciences and Drug Research, Punjabi University, Patiala, India.
Journal of Molecular Graphics & Modelling
|August 10, 2000
Summary
A new connective eccentricity index accurately predicts antihypertensive activity in N-benzylimidazole derivatives. This topological descriptor shows improved performance over existing methods for drug discovery.
Area of Science:
- Medicinal Chemistry
- Cheminformatics
- Pharmacology
Background:
- Angiotensin II receptor antagonists are crucial for treating hypertension.
- Existing QSAR methods have limitations in predicting drug efficacy.
- N-benzylimidazole derivatives represent a promising class of antihypertensive agents.
Purpose of the Study:
- To introduce and evaluate a novel topological descriptor, the connective eccentricity index.
- To assess the predictive power of this index for antihypertensive activity.
- To compare its performance against Balaban's mean square distance index.
Main Methods:
- Conceptualization of the connective eccentricity index based on graph theory.
- Application of the index to a dataset of 81 N-benzylimidazole derivatives.
- Correlation of computed index values with reported antihypertensive activity.
Main Results:
- The connective eccentricity index was computed for all derivatives.
- An active range for the index was identified.
- The index demonstrated superior predictive accuracy compared to Balaban's index.
- Approximately 80% prediction accuracy was achieved within the active range.
Conclusions:
- The connective eccentricity index is a valuable tool for predicting antihypertensive activity.
- This descriptor offers improved performance for drug discovery in antihypertensive agents.
- The findings support the use of graph-theoretic descriptors in QSAR studies.